July 7, 2020
The Ministry of Health, Labor and Welfare (MHLW) is now set to approve new indications for a batch of big-name drugs, including Chugai Pharmaceutical’s breast cancer agent Kadcyla (trastuzumab emtansine) for adjuvant therapy, with their approval plans slated to be...read more